Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply

Joseph A. Sparano

doi:10.1056/NEJMc1909693

Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply

Joseph A. Sparano

Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1290-1291
Number of pages	2
Journal	The New England journal of medicine
Volume	381
Issue number	13
DOIs	https://doi.org/10.1056/NEJMc1909693
State	Published - Sep 26 2019

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJMc1909693

Cite this

@article{31e92358ff2c499eaec224636c37de8e,

title = "Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply",

author = "Sparano, {Joseph A.}",

year = "2019",

month = sep,

day = "26",

doi = "10.1056/NEJMc1909693",

language = "English (US)",

volume = "381",

pages = "1290--1291",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "13",

}

TY - JOUR

T1 - Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply

AU - Sparano, Joseph A.

PY - 2019/9/26

Y1 - 2019/9/26

UR - http://www.scopus.com/inward/record.url?scp=85072652589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072652589&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1909693

DO - 10.1056/NEJMc1909693

M3 - Letter

C2 - 31553846

AN - SCOPUS:85072652589

SN - 0028-4793

VL - 381

SP - 1290

EP - 1291

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 13

ER -

Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this